Advertisement
News
Advertisement

St. Jude Medical slides on potential FDA warning, lowered outlook

Wed, 10/17/2012 - 11:27am
Mass Device

Shares of St. Jude Medical are down more than 6% today after the medical device company said it might get a warning letter from the FDA over a California plant and lowered its outlook for the rest of the year.

St. Jude Medical

St. Jude Medical's (NYSE:STJ) stock took a hit today after the medical device company said it might get a warning from the FDA over its YY and lowered its outlook for the rest of the year.

The beleaguered St. Paul-based firm has had a rough go of it lately, waging a spat with a key supplier and weathering high-profile exposure for its handling of the recall of its Riata defibrillator leads. This morning St. Jude CEO Daniel Starks told analysts on a conference call that the federal watchdog agency might slap the company with a Form 483 warning letter over a cardiac rhythm management plant in Sylmar, Calif.

"It's a risk, and don't be shocked if that risk is realized," Starks said, according to Reuters.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading